DNM2 and breast carcinoma: To monitor the impact of AVP stimulation and Dyn2 inhibition on breast cancer cells invasion, transwell assay was performed after cells being treated with AVP, DYN+AVP, DYN+Wort, and AVP/Wort/DYN.